Regenerative Medicine Market Analysis and Forecast Report 2024

Regenerative medicine is a comparatively new area of science that involves the restoration of damaged cells, tissues or organs by applying cell therapy, tissue engineering, immunotherapy or gene therapy techniques. On contrary to the present clinical therapeutics that act on slowing the disease progression or relieve symptoms, regenerative medication has a promising therapeutic approach of restoring the function and structure of damaged organs and tissues.

Request for report sample at: https://www.psmarketresearch.com/market-analysis/regenerative-medicine-market/report-sample

The global regenerative medicine market is expected to witness significant growth during the forecast period (2017–2023), due to the increase in the prevalence of chronic diseases, orthopaedic injuries, genetic disorders, growing aging population, increasing government funding along with the private funding in the research & development of regenerative medicines with the advancement in nanotechnology based drug delivery system, and moderate healthcare reforms. Currently, major breakthrough in the area is the development of tissue engineered trachea, transplantation of retinal pigment differentiated by stem cell based therapy to treat age-related macular degeneration. However, recently research labs have started to focus on regenerating solid organs such as heart, kidney, lungs and other organs to curb the problems associated with organ transplantation.

Technological innovations in the area of stem cell therapy and tissue engineering has led to rapid growth of the regenerative medicine market size. The key factors which drive the growth of the global market include increase in the demand of orthopaedic surgeries, government healthcare reforms in certain countries such as the U.S. and Canada, aging population, rise in chronic diseases, increasing prevalence of bone and joint diseases, and innovations in nanotechnology that aids in drug delivery mechanism.

However, stringent regulations, ethical issues, and the risk of product failure and their recall are the key barriers for the growth of the regenerative medicine market. The cost of regenerative medicine treatment is significantly high and it is less effective in case of geriatric patients, which hinders the growth of the global market to some extent.

Browse full report at: https://www.psmarketresearch.com/market-analysis/regenerative-medicine-market

Key companies are acquiring other companies to strengthen their regenerative medicine market share. For instance, in August 2016, Medtronic Inc. had acquired Heart Ware International, Inc., that offers less-invasive, miniaturized, mechanical circulatory support (MCS) techniques as an advanced heart failure treatment. This acquisition was aimed at increasing the working efficiency of the company and to broaden its product portfolio.

Some of the other key players operating in the global market include Acelity L.P. Inc., NuVasive Inc., Vericel Corporation, Osiris therapeutics Inc., Integra Lifesciences Corporation, Stryker Corporation, Cook Biotech Incorporated, Organogenesis Inc., and Japan Tissue Engineering Co. Ltd.

Source: P&S Intelligence

Orthobiologics Market Analysis, Growth, Prospect, Trends and Forecast to 2024

The global orthobiologics market is driven by increasing sports injuries and road accidents, increased obesity rate, growing awareness among people, and surging aging population. Moreover, the opportunities witnessed in the global market include development in implant technologies and shifting demand from mechanical to biological solutions. The global market has been classified in terms of product, application, end-user and geography. Based on product, the global market is segmented into bone morphogenetic proteins, demineralized bone matrix, synthetic bone substitute, allograft, viscosupplementation, machined bones, and stem cell therapy. Based on end user, the global market is segmented into orthopedic clinics, hospitals, and others.

Request for report sample at: https://www.psmarketresearch.com/market-analysis/orthobiologics-market/report-sample

The viscosupplementation segment accounted for the highest market share among the various products in the global orthobiologics market. However, the patients and medical practitioners are also developing an interest for the stem-cell-based products and synthetic bone substitutes, thus leading to their increased popularity. Both the stem cell therapy and synthetic bone substitute segments would witness significant growth during the forecast period. Based on application, the global market has been segmented into reconstructive surgery, spinal fusion, and trauma. The reconstructive surgery segment would account for the highest growth during the forecast period, due to increasing number of hip and knee replacement surgeries.

The geographical segmentation of the global orthobiologics market includes North America, Europe, Asia-Pacific and Rest of the World (RoW). North America and Europe accounted for major share in the global market, since the regions have the highest aging population, due to increase in life expectancy and prevalence of geriatric-based diseases, such as diabetes, arthritis, and obesity. The Asia-Pacific market is expected to witness surge, due to the enormous untapped patient population, increasing medical tourism, and economical treatment cost. The developing nations, such as India and China, in the Asia-Pacific market are expected to witness significant growth.

Browse full report at: https://www.psmarketresearch.com/market-analysis/orthobiologics-market

The major companies operating in the global orthobiologics market include Exactech Inc., Medtronic plc., Stryker Corporation, Synthes Inc., Smith & Nephew Plc, Zimmer Biomet, DePuy Synthes Inc (Johnson & Johnson), Tornier Inc., and others.

Source: P&S Intelligence

Next-Generation Sequencing Market Will Make a Huge Impact in near Future

The global next-generation sequencing market is growing significantly due to advances in next-generation technologies, increasing scientists and researchers’ compliance for next-generation sequencing, and low cost of next-generation sequencing methods compared to conventional sequencing methods in the industry. The unexplored next-generation sequencing market in emerging economies and increasing focus for the development of personalized medicine are creating opportunities for the global next-generation sequencing market to grow at a considerable rate in the coming years.

Download free report sample at: https://www.psmarketresearch.com/market-analysis/next-generation-sequencing-market/report-sample

The advanced research and development activities by the major players are propelling the demand for cost effective and efficient next-generation sequencing platforms. However, interpretation of large volume of complex sequencing data through next-generation sequencing platforms is a major challenge in global next-generation sequencing market.

Usage of nanopore sequencing technology for the development of next-generation sequencing platforms is a trend in global next-generation sequencing market. Next-generation sequencing provides high throughput sequencing to researchers and scientists with high specificity and speed, and reduced cost. Conventional sequencing methods, such as Sanger method that are slower, expensive and require large amount of template DNA next-generation sequencing, has overcome these limitations with more accurate results.

Geographically, North America will be leading the global next-generation sequencing market in the coming years due to high healthcare expenditure, technological advancements, presence of large number of academic and research institutes, and high scientists’ compliance for next-generation sequencing devices.

Some of the major players operating in the global next-generation sequencing market are Agilent Technologies, Inc., F. Hoffmann-La Roche AG, Biomatters, Ltd., GATC Biotech AG, Illumina, Inc., Thermo Fisher Scientific, Inc., Pacific Biosciences, Oxford Nanopore Technologies, Ltd, Macrogen, Inc. among others.

Source: P&S Intelligence

Pharmaceutical Membrane Technology Market and its Growth Prospect in the Coming Years

Globally, the pharmaceutical membrane technology market is projected to showcase notable growth during the forecast period, mainly due to increasing pharmaceutical production, rising research and development (R&D) activities, and growing demand for generic drugs in the developing nations.

Request for report sample at: https://www.psmarketresearch.com/market-analysis/pharmaceutical-membrane-technology-market/report-sample

Based on product, the pharmaceutical membrane technology market is sub-segmented into coated cellulose acetate, nylon, mixed cellulose ester (MCE) membrane filters, polytetrafluoroethylene (PTFE) membrane, polyvinylidene fluoride (PVDF) membrane, and other membrane filters. Of these, MCE membrane filters hold the largest share in the global market, as they are biologically inert and most commonly used in analytical and research applications.

Europe is expected to hold the second-largest share in the pharmaceutical membrane technology market. Increasing pharmaceutical production, presence of large number of pharmaceutical companies, and rising government support in the form of funds and grants are the major factors driving the growth of the market. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), the pharmaceutical industry invested $41.8 billion on the R&D annually, which in turn would boost the demand for pharmaceutical membrane technologies and products in the region.

Growing pharmaceutical industry, rising pharmaceutical production, increasing R&D investments, and growing demand of generic drugs are some of the major factors driving the growth of the global pharmaceutical membrane technology market.

Browse full report at: https://www.psmarketresearch.com/market-analysis/pharmaceutical-membrane-technology-market

Globally, increasing prevalence of chronic and infectious diseases is fostering the growth of the pharmaceutical industry by spurring the demand of pharmaceutical products, which further plays a substantial role in the growth of pharmaceutical membrane technology industry. According to the report “The Pharmaceutical Industry and Global Health, Facts and Figures 2017”, published by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), the global pharmaceutical industry was valued at $997 billion in 2014.

Some of the key players operating in the pharmaceutical membrane technology market include Merck KGaA, Sartorius AG, General Electric Company, 3M Company, Danaher Corporation, Lenntech BV, Koch Membrane Systems Inc., and Graver technologies LLC.

Source: P&S Intelligence

LATAM Wound Dressing Market Growth Factors, Applications, Regional Analysis and Forecasts by 2024

The Latin American wound dressing market is expected to reach $400.9 million by 2024. The market growth is primarily driven by growing geriatric population, rising prevalence of diabetes, high rate of brain injuries, and increasing number of patients with chronic wounds in the region.

Request for report sample at: https://www.psmarketresearch.com/market-analysis/latam-wound-dressing-market/report-sample

Based on type, the Latin American wound dressing market is bifurcated into advanced and traditional dressings. The category of advanced wound dressings is estimated to hold over 60.0% share in the market in 2018. This can be mainly ascribed to the growing use of these dressings in complex areas of application and the increasing prevalence of chronic diseases in the region. Advanced wound dressings are further classified into foams, hydrocolloids, films, alginates, hydrogels, collagen, hydrofiber, wound contact layers, superabsorbent, and other dressings. Among these, foam dressings are the most commonly used advanced dressings in the region and witness a high demand in the Latin American advanced wound dressing market.

Wound dressings are used for the treatment and management of chronic and acute wounds. Chronic wounds require higher application of wound dressings as compared to acute wounds, mainly due to the greater severity of these wounds. Based on application, the category of chronic wound dressings is estimated to generate revenue of approximately $200 million in the Latin American wound dressing market in 2018. The Latin American acute wound dressing market is further bifurcated into burns and surgical and traumatic wounds, of which the category of surgical and traumatic wound dressings is estimated to hold the larger market share, accounting for 91.0%, in 2018.

Browse full report at: https://www.psmarketresearch.com/market-analysis/latam-wound-dressing-market

Some of the other key players operating in the Latin American wound dressing industry are Hollister Incorporated; DeRoyal Industries Inc.; Johnson & Johnson; Smith & Nephew plc; Mölnlycke Health Care AB; 3M Company; Acelity L.P. Inc.; BSN Medical GmbH; HARTMANN GROUP; B. Braun Melsungen AG; and Coloplast A/S.

Source: P&S Intelligence